SEC 13F Intelligence

Mpm Bioimpact LLC / TRVI

Mpm Bioimpact LLC’s Trevi Therapeutics Inc Position

Does Mpm Bioimpact LLC own Trevi Therapeutics Inc (TRVI)? Yes — 3.30M shares worth $39M (+3.04% of its 13F portfolio) as of Q1 2026, up from 3.29M shares the prior filed quarter.

Position Value
$39M
Q1 2026
Shares
3.30M
% of Portfolio
+3.04%
Quarters Held
9
currently held

Position History TRVI

Reported value by quarter
Q1 ’24: $5MQ1 ’24Q2 ’24: $5MQ3 ’24: $5MQ3 ’24Q4 ’24: $13MQ1 ’25: $22MQ1 ’25Q2 ’25: $19MQ3 ’25: $31MQ3 ’25Q4 ’25: $41MQ1 ’26: $39MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20263.30M$39M+3.04%
Q4 20253.29M$41M+4.71%
Q3 20253.41M$31M+5.10%
Q2 20253.41M$19M+3.23%
Q1 20253.43M$22M+3.71%
Q4 20243.09M$13M+1.81%
Q3 20241.54M$5M+0.77%
Q2 20241.51M$5M+0.70%
Q1 20241.34M$5M+0.74%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mpm Bioimpact LLC’s full portfolio or all institutional holders of TRVI.